Werbung
Werbung
CRVS
Corvus Pharmaceuticals, Inc.
6.79
USDGesponsert
-0.13
-1.94%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
6.85
+0.06
+0.94%
CRVS Ergebnisberichte
Positives Überraschungsverhältnis
CRVS übertreffen die 22 der letzten 39Schätzungen.
56%
Nächster Bericht
Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.13
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+8.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-27.78%
Corvus Pharmaceuticals, Inc. earnings per share and revenue
On 04. Nov. 2025, CRVS reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.13 USD, resulting in a 11.83% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.44% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an increase of 8.33% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Corvus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Corvus Pharmaceuticals, Inc. reported EPS of -$0.12, beating estimates by 11.83%, and revenue of $0.00, 0% as expectations.
How did the market react to Corvus Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -1.44%, changed from $7.64 before the earnings release to $7.53 the day after.
When is Corvus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 23. März 2026.
What are the forecasts for Corvus Pharmaceuticals, Inc.'s next earnings report?
Based on 9
analysts, Corvus Pharmaceuticals, Inc. is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung